We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.83B
AUM Growth
+$108M
(+2.3%)
Cap. Flow
+$83.9M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
12.94%
Holding
1,335
New
249
Increased
372
Reduced
442
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$35.5M |
| 2 |
CVS Health
CVS
|
+$32.5M |
| 3 |
Biogen
BIIB
|
+$24.9M |
| 4 |
Citigroup
C
|
+$23.8M |
| 5 |
PAY
Verifone Systems Inc
PAY
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$31.7M |
| 2 |
Comcast
CMCSA
|
+$23.5M |
| 3 |
Verizon
VZ
|
+$23.2M |
| 4 |
Amazon
AMZN
|
+$22.2M |
| 5 |
Eli Lilly
LLY
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Financials | 15.76% |
| 3 | Healthcare | 13.7% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XOMA
976
DELISTED
Xoma
XOMA
| $229K | ﹤0.01% |
20,806
-3,385
| -14% | -$48.5K |
|
|
PAMT
977
PAMT Corp
PAMT
$340M
| $229K | ﹤0.01% |
+57,596
| New | +$311K |
|
|
CERN
978
DELISTED
Cerner Corp
CERN
| $229K | ﹤0.01% |
3,900
-58,150
| -94% | -$3.24M |
|
|
MACK
979
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $229K | ﹤0.01% |
+5,389
| New | +$294K |
|
|
PMBC
980
DELISTED
Pacific Mercantile Bancorp
PMBC
| $228K | ﹤0.01% |
32,164
+2,400
| +8% | +$17.5K |
|
981
Ubiquiti
UI
$31.8B
| $222K | ﹤0.01% |
+5,730
| New | +$213K |
|
|
VAR
982
DELISTED
Varian Medical Systems, Inc.
VAR
| $222K | ﹤0.01% |
3,079
-42,468
| -93% | -$3.08M |
|
983
Inseego
INSG
$108M
| $221K | ﹤0.01% |
14,516
-1,810
| -11% | -$27.8K |
|
|
MAGN
984
Magnera Corp
MAGN
$488M
| $221K | ﹤0.01% |
869
-621
| -42% | -$167K |
|
|
CSGS
985
DELISTED
CSG Systems International
CSGS
| $220K | ﹤0.01% |
5,470
| – | – |
|
|
HTLF
986
DELISTED
Heartland Financial USA, Inc.
HTLF
| $220K | ﹤0.01% |
+6,240
| New | +$209K |
|
|
QADA
987
DELISTED
QAD Inc.
QADA
| $220K | ﹤0.01% |
+11,399
| New | +$225K |
|
988
Ampco-Pittsburgh
AP
$167M
| $218K | ﹤0.01% |
19,289
-3,500
| -15% | -$53.6K |
|
989
Cognizant
CTSH
$21.5B
| $217K | ﹤0.01% |
3,790
+470
| +14% | +$28.4K |
|
990
State Street
STT
$50.9B
| $217K | ﹤0.01% |
4,030
-1,650
| -29% | -$98.6K |
|
|
ECYT
991
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $217K | ﹤0.01% |
+67,493
| New | +$247K |
|
992
Coherus Oncology
CHRS
$217M
| $216K | ﹤0.01% |
+12,800
| New | +$240K |
|
|
FRTX
993
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $215K | ﹤0.01% |
151
| – | – |
|
|
HGG
994
DELISTED
hhgregg Inc.
HGG
| $215K | ﹤0.01% |
121,360
+111,260
| +1,102% | +$194K |
|
|
ESI
995
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $215K | ﹤0.01% |
112,000
+15,700
| +16% | +$35.5K |
|
|
ALSK
996
DELISTED
Alaska Communications Systems
ALSK
| $213K | ﹤0.01% |
125,097
+39,922
| +47% | +$71.4K |
|
|
SYNC
997
DELISTED
Synacor, Inc.
SYNC
| $213K | ﹤0.01% |
69,079
-6,100
| -8% | -$15.4K |
|
998
Dave & Buster's
PLAY
$343M
| $211K | ﹤0.01% |
+4,510
| New | +$187K |
|
|
GNCA
999
DELISTED
Genocea Biosciences, Inc.
GNCA
| $211K | ﹤0.01% |
6,425
-4,262
| -40% | -$156K |
|
1000
Cytokinetics
CYTK
$11B
| $210K | ﹤0.01% |
22,130
-51,957
| -70% | -$426K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2016 Portfolio in Review
As of Q2 2016, Jacobs Levy Equity Management held 1,335 positions worth $4.83B, up 2.3% from $4.72B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2016 filing shows 249 new, 372 increased, 442 reduced and 194 closed positions. Its largest new stake was CVS Health: 325,716 shares worth $31.2M. The largest sale was Targa Resources, an estimated $31.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q2 2016 buy was CVS Health: 325,716 shares worth $31.2M.
- Jacobs Levy Equity Management added most to Microsoft in Q2 2016, an estimated $35.5M increase.
- Jacobs Levy Equity Management's biggest Q2 2016 reduction was Comcast, cutting an estimated $23.5M.
- Jacobs Levy Equity Management fully exited Targa Resources in Q2 2016, selling an estimated $31.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.83B portfolio in Q2 2016.
- Jacobs Levy Equity Management opened 249 new positions and closed 194 in Q2 2016.
- Jacobs Levy Equity Management's portfolio value rose 2.3% quarter-over-quarter to $4.83B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2016, filed 15 Aug 2016.